Preoperative antiepileptic drug prophylaxis for early postoperative seizures in supratentorial meningioma: a single-center experience
Tóm tắt
Perioperative antiepileptic drug (AED) prophylaxis for early postoperative seizures (EPSs) in patients with supratentorial meningiomas without preoperative seizures is controversial. This paper discusses the incidence, risk factors, control rate and AED withdrawal indications of EPS in patients undergoing supratentorial convexity and parasagittal/falx meningioma resection without preoperative seizures. Patients treated for a histologically confirmed supratentorial convexity and parasagittal/falx meningioma at the authors’ institution between 2015 and 2021 were retrospectively examined. Clinical and imaging data were assessed. Variates were analyzed using univariate and multivariate regression analyses. A PubMed review of the literature published between 2011 and 2021 was performed. In total, 517 patients met the selection criteria. EPS (within the first postoperative week) was observed in 30/517 cases (5.8%). Multivariate analysis revealed that surgical/medical complications (OR 16.33, 95% CI 7.07–37.7, P < 0.001) were the only independent predictors of EPS. The dose of valproic was increased and levetiracetam was added based on the frequency of seizures (≤ 2, > 2 times and status epilepticus). EPS control rates were 94.1% (16/17) and 92.3% (12/13), respectively. AEDs were discontinued at 2 weeks and 4–6 weeks, respectively. The authors identified 10 relevant studies in the literature. Based on their review of the literature, the incidence of EPS was 3.7% (47/1282) with AED use and 6.2% (95/1525) without AED use patients in supratentorial meningiomas without preoperative seizures. The incidence of EPS was 9.0% (19/209) in patients without AED use with convexity and parasagittal/falx meningiomas without preoperative seizures. AED prophylaxis can reduce the incidence of EPS in patients with convexity and parasagittal/falx meningiomas without preoperative seizures. Avoiding postoperative complications is an important means to prevent EPS. Combined medication has a significant effect on controlling repeated EPS. The timing of AED withdrawal was evaluated according to the clinical symptoms and imaging findings.
Tài liệu tham khảo
Joiner Evan F, Youngerman Brett E, Hudson Taylor S et al (2019) Effectiveness of perioperative antiepileptic drug prophylaxis for early and late seizures following oncologic neurosurgery: a meta-analysis. J Neurosurg 130:1274–1282
Jin Michael C, Parker Jonathon J, Zhang M et al (2021) Status epilepticus after intracranial neurosurgery: incidence and risk stratification by perioperative clinical features. J Neurosurg 14:1–13
Glantz MJ, Cole BF, Forsyth PA et al (2000) Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 54:1886–1893
Olson Jeffrey J, Kalkanis Steven N, Ryken Timothy C (2015) Evidence-based clinical practice parameter guidelines for the treatment of adults with diffuse low grade glioma: introduction and methods. J Neurooncol 125:449–456
Wu AS, Trinh VT, Suki D et al (2013) A prospective randomized trial of perioperative seizure prophylaxis in patients with intraparenchymal brain tumors. J Neurosurg 118:873–883
Islim AI, Ali A, Bagchi A et al (2018) Postoperative seizures in meningioma patients: improving patient selection for antiepileptic drug therapy. J Neurooncol 140:123–134
Ansari Shaheryar F, Bohnstedt Bradley N, Perkins Susan M et al (2014) Efficacy of postoperative seizure prophylaxis in intra-axial brain tumor resections. J Neurooncol 118:117–122
Chen William C, Magill Stephen T, Englot Dario J et al (2017) Factors associated with pre- and postoperative seizures in 1033 patients undergoing supratentorial meningioma resection. Neurosurgery 81:297–306
Youngerman BE, Joiner EF, Wang X et al (2020) Patterns of seizure prophylaxis after oncologic neurosurgery. J Neurooncol 146:171–180
Toshihiko I, Kiyoto K, Minako M et al (2015) Levetiracetam versus phenytoin for seizure prophylaxis during and early after craniotomy for brain tumours: a phase II prospective, randomised study. J Neurol Neurosurg Psychiatry 86:1158–1162
Dewan MC, Thompson RC, Kalkanis SN et al (2017) Prophylactic antiepileptic drug administration following brain tumor resection: results of a recent AANS/CNS Section on Tumors survey. J Neurosurg 126:1772–1778
Englot Dario J, Magill Stephen T, Han Seunggu J et al (2016) Seizures in supratentorial meningioma: a systematic review and meta-analysis. J Neurosurg 124:1552–1561
Peter B, Mana S, Daniel M et al (2021) Early and late postoperative seizures in meningioma patients and prediction by a recent scoring system. Cancers 13:450
Marco S, Christian R, Susan N et al (2017) Risk factors of preoperative and early postoperative seizures in patients with meningioma: a retrospective single-center cohort study. World Neurosurg 97:538–546
Ersoy TF, Ridwan S, Grote A et al (2020) Early postoperative seizures (EPS) in patients undergoing brain tumour surgery. Sci Rep 10:13674
Lu VM, Wahood W, Akinduro OO et al (2019) Four independent predictors of postoperative seizures after meningioma surgery: a meta-analysis. World Neurosurg 130:537–545
Hai X, Olafur S, Jiri B et al (2018) Long-term control and predictors of seizures in intracranial meningioma surgery: a population-based study. Acta Neurochir (Wien) 160:589–596
Xiangrong Li, Chengjun W, Zhiqin L et al (2020) Risk factors and control of seizures in 778 Chinese patients undergoing initial resection of supratentorial meningiomas. Neurosurg Rev 43:597–608
Kihwan H, Jin-Deok J, Young-Hoon K et al (2019) Risk factors for preoperative and late postoperative seizures in primary supratentorial meningiomas. Clin Neurol Neurosurg 180:34–39
Wang Y-C, Chuang C-C, Tu P-H et al (2018) Seizures in surgically resected atypical and malignant meningiomas: Long-term outcome analysis. Epilepsy Res 140:82–89
Peng Z, Yuping Li, Jun Z et al (2020) Risk factors analysis and a nomogram model establishment for late postoperative seizures in patients with meningioma. J Clin Neurosci 80:310–317
Xu Jiadong Yu, Yaoyao LQ et al (2021) Radiomic features as a risk factor for early postoperative seizure in patients with meningioma. Seizure 93:120–126
Seyedi JF, Pedersen CB, Poulsen FR (2018) Risk of seizures before and after neurosurgical treatment of intracranial meningiomas. Clin Neurol Neurosurg 165:60–66
Temkin NR (2002) Prophylactic anticonvulsants after neurosurgery. Epilepsy Curr 2:105–107
Hans-Georg W, Corinne M, Corinne G et al (2016) Predicting outcome of epilepsy after meningioma resection. Neuro Oncol 18:1002–1010
Magill Stephen T, Theodosopoulos Philip V, McDermott Michael W (2016) Resection of falx and parasagittal meningioma: complication avoidance. J Neurooncol 130:253–262
Fuller KL, Wang YY, Cook MJ et al (2013) Tolerability, safety, and side effects of levetiracetam versus phenytoin in intravenous and total prophylactic regimen among craniotomy patients: a prospective randomized study. Epilepsia 54:45–57
van der Meer PB, Dirven L, Fiocco M et al (2021) First-line antiepileptic drug treatment in glioma patients with epilepsy: Levetiracetam vs valproic acid. Epilepsia 62:1119–1129